BioGaia AB (publ) (BIOG-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) has a cash flow conversion efficiency ratio of 0.064x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr83.52 Million ≈ $8.99 Million USD) by net assets (Skr1.31 Billion ≈ $141.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioGaia AB (publ) - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how BioGaia AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does BioGaia AB (publ) carry for a breakdown of total debt and financial obligations.
BioGaia AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioGaia AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lindab International AB
ST:LIAB
|
0.071x |
|
Shandong Hi-Speed Road&Bridge
SHE:000498
|
0.011x |
|
Shaily Engineering Plastics Limited
NSE:SHAILY
|
0.155x |
|
Hunan Friendship&Apollo Commercial Co Ltd
SHE:002277
|
0.015x |
|
Shin Zu Shing Co Ltd
TW:3376
|
0.012x |
|
Oil Refineries Ltd.
TA:ORL
|
0.108x |
|
WIZZ AIR HLDG.UNSP.ADR/4
F:WI20
|
N/A |
|
C3 Ai Inc
NYSE:AI
|
-0.062x |
Annual Cash Flow Conversion Efficiency for BioGaia AB (publ) (2002–2025)
The table below shows the annual cash flow conversion efficiency of BioGaia AB (publ) from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see BioGaia AB (publ) (BIOG-B) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr1.31 Billion ≈ $141.43 Million |
Skr306.57 Million ≈ $32.99 Million |
0.233x | +7.75% |
| 2024-12-31 | Skr1.72 Billion ≈ $185.52 Million |
Skr373.22 Million ≈ $40.16 Million |
0.216x | +3.19% |
| 2023-12-31 | Skr2.03 Billion ≈ $218.50 Million |
Skr425.96 Million ≈ $45.84 Million |
0.210x | +29.74% |
| 2022-12-31 | Skr1.97 Billion ≈ $212.26 Million |
Skr318.94 Million ≈ $34.32 Million |
0.162x | +36.82% |
| 2021-12-31 | Skr1.88 Billion ≈ $202.03 Million |
Skr221.88 Million ≈ $23.88 Million |
0.118x | -6.72% |
| 2020-12-31 | Skr1.75 Billion ≈ $187.92 Million |
Skr221.26 Million ≈ $23.81 Million |
0.127x | -56.48% |
| 2019-12-31 | Skr507.87 Million ≈ $54.66 Million |
Skr147.85 Million ≈ $15.91 Million |
0.291x | -19.22% |
| 2018-12-31 | Skr508.12 Million ≈ $54.68 Million |
Skr183.12 Million ≈ $19.71 Million |
0.360x | -24.90% |
| 2017-12-31 | Skr463.89 Million ≈ $49.92 Million |
Skr222.62 Million ≈ $23.96 Million |
0.480x | +34.69% |
| 2016-12-31 | Skr415.18 Million ≈ $44.68 Million |
Skr147.93 Million ≈ $15.92 Million |
0.356x | +20.03% |
| 2015-12-31 | Skr395.83 Million ≈ $42.60 Million |
Skr117.50 Million ≈ $12.64 Million |
0.297x | -17.76% |
| 2014-12-31 | Skr344.59 Million ≈ $37.08 Million |
Skr124.38 Million ≈ $13.39 Million |
0.361x | +45.81% |
| 2013-12-31 | Skr316.86 Million ≈ $34.10 Million |
Skr78.44 Million ≈ $8.44 Million |
0.248x | -66.30% |
| 2012-12-31 | Skr456.79 Million ≈ $49.16 Million |
Skr335.56 Million ≈ $36.11 Million |
0.735x | +132.47% |
| 2011-12-31 | Skr230.35 Million ≈ $24.79 Million |
Skr72.79 Million ≈ $7.83 Million |
0.316x | -14.17% |
| 2010-12-31 | Skr187.32 Million ≈ $20.16 Million |
Skr68.97 Million ≈ $7.42 Million |
0.368x | +11.31% |
| 2009-12-31 | Skr161.12 Million ≈ $17.34 Million |
Skr53.29 Million ≈ $5.73 Million |
0.331x | +128.07% |
| 2008-12-31 | Skr132.42 Million ≈ $14.25 Million |
Skr19.20 Million ≈ $2.07 Million |
0.145x | +170.52% |
| 2007-12-31 | Skr94.91 Million ≈ $10.21 Million |
Skr5.09 Million ≈ $547.55K |
0.054x | +580.80% |
| 2006-12-31 | Skr74.53 Million ≈ $8.02 Million |
Skr-831.00K ≈ $-89.43K |
-0.011x | +91.97% |
| 2005-12-31 | Skr71.78 Million ≈ $7.72 Million |
Skr-9.97 Million ≈ $-1.07 Million |
-0.139x | -155.28% |
| 2004-12-31 | Skr91.50 Million ≈ $9.85 Million |
Skr22.99 Million ≈ $2.47 Million |
0.251x | +27.74% |
| 2003-12-31 | Skr114.85 Million ≈ $12.36 Million |
Skr22.59 Million ≈ $2.43 Million |
0.197x | -14.88% |
| 2002-12-31 | Skr127.99 Million ≈ $13.77 Million |
Skr29.57 Million ≈ $3.18 Million |
0.231x | -- |
About BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more